Abbott CEO Robert Ford warned that 'the industry is at risk,' implicating that continued litigation may force them to withdraw specialized formulas from the market.
The American Academy of Pediatrics cautioned that ongoing litigation could threaten the availability of infant formulas, suggesting the condition necrotizing enterocolitis has multiple causes beyond formula use.
Experts indicate that without government intervention, specifically indemnification programs, the current legal environment makes it increasingly hard for formula companies to navigate these lawsuits.
A notable judgment against Reckitt Benckiser raises concerns that the legal challenges might restrict access to essential nutritional products essential for premature infants.
#necrotizing-enterocolitis #infant-formula #lawsuits #premature-babies #food-and-drug-administration
[
Collection
]
[
|
...
]